UBS Downgrades Emerson (EMR) to Sell
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
UBS downgraded Emerson (NYSE: EMR) from Neutral to Sell with a price target of $44.00 (from $53.00).
Shares of Emerson closed at $50.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Cowen Downgrades Under Armour, Inc. (UA) to Market Perform
- Emerson Delivers New Cloud-Based Industrial Internet of Things Solutions
- FBR Capital Downgrades FuelCell Energy (FCEL) to Market Perform
Create E-mail Alert Related CategoriesDowngrades, Hot Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!